MedTrace Logo

Effectiveness of Dry Needling in Athletes With Chronic Hamstring Strain

NCT07569484 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-05-06

No results posted yet for this study

Summary

This study aims to evaluate the effectiveness of dry needling in reducing pain and improving functional outcomes in athletes with chronic hamstring strain. Chronic hamstring injuries are common among athletes and often lead to persistent pain, reduced performance, and limitations in daily and sports activities.

Dry needling is a therapeutic technique used to target myofascial trigger points and relieve muscle tension. This study will compare the effects of dry needling with conventional physiotherapy interventions to determine its role in managing chronic hamstring strain.

Participants will be athletes diagnosed with chronic hamstring strain. Outcomes will include pain intensity, muscle flexibility, and functional performance. The results of this study may help improve rehabilitation strategies and provide evidence for the use of dry needling in sports injuries.

Conditions

  • Hamstring Muscle Strain

Interventions

PROCEDURE

Dry Needling

Participants will receive dry needling treatment applied to active myofascial trigger points in the hamstring muscles (biceps femoris, semitendinosus, and semimembranosus). Sterile filiform needles will be inserted into identified trigger points to elicit local twitch responses and reduce muscle pain and tightness. Treatment will be performed in addition to a standardized rehabilitation program including stretching and strengthening exercises for the hamstring muscle group. Sessions will be administered over the study period according to a predefined treatment schedule.

PROCEDURE

Standard Rehabilitation Program

Participants will receive a standardized rehabilitation program including stretching and eccentric strengthening exercises for hamstring muscles without dry needling.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Amr Anas, BSc · Cairo University

  • Ebtessam Gomaa, PhD · Cairo University

  • Marihan Makary · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2026-09-30
Completion
2027-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07569484 on ClinicalTrials.gov